Skip to search formSkip to main contentSkip to account menu

NHL-BFM-90 Regimen

Known as: BFM-90 Regimen 
A regimen used for the treatment of localized aggressive forms of childhood B-cell non-Hodgkin's lymphoma, including lymphoblastic lymphoma.
National Institutes of Health

Related topics

Related topics

15 relations
ASPARAGINASEChildhood Anaplastic Large Cell LymphomaChildhood Diffuse Large B -Cell LymphomaCyclophosphamide

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
[Long-term clinical outcome of children and adolescents with Burkitt's lymphoma treated with rituximab combined with modified NHL-BFM-90 regimen].
Objective: To evaluate the efficacy and safety of rituximab combined with the modified NHL-BFM-90 protocol in childhood and… 
Review
2018
Review
2018
Successful experience of treatment of a patient with generalized non-GCB- DLBCL using the R-mNHL-BFM-90 protocol with lenalidomide: case report and review of literature.
Diffuse large B-cell lymphoma is categorized by gene expression profiling into germinal center (GCB) and activated B-cell (ABC… 
2014
2014
Влияние программной химиотерапии на функциональное состояние головного мозга у детей с лимфоидными опухолями (Е.И. Кузнецова)
The aim of this work was assessment of the brain functional state and to find an electroencephalogramm (EEG)-predictors of… 
2009
2009
[First experience of using modified program NHL-BFM-90 for the treatment of primary diffuse large-B-cell lymphosarcoma of the bones and soft tissues with poor-prognosis].
AIM To evaluate efficacy of intensive modified program NHL-BFM-90 (mNHL-BFM-90) in adult poor-prognosis patients with diffuse… 
2007
2007
[Modified BFM-90 regimen greatly improves treatment outcomes of chinese childhood and adolescent lymphoblastic lymphoma].
OBJECTIVE This study was designed to evaluate the efficacy and toxicity of modified BFM-90 regimen originated from Germany… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)